Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth

Journal of Ethnopharmacology

Volumn 124, Issue 2, 2009, Pages 284-288

  Aguilar Santamaria L ^a   Ramirez G ^a   Nicasio, P ^a   Alegria Reyes C ^a   Herrera Arellano, A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Glucosidase inhibition; Bignoniaceae; Hypolipidemic effects; Phenolic compounds; Postprandial hyperglycemia; Tecoma stans; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE; LIPID; PHENOL DERIVATIVE; PLANT EXTRACT; STARCH; TECOMA STANS EXTRACT; TOLBUTAMIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; ENZYME INHIBITION; ETHNOPHARMACOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INTESTINE BRUSH BORDER; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; RAT; STREPTOZOCIN DIABETES; TECOMA STANS; TRIACYLGLYCEROL BLOOD LEVEL;

ACARBOSE; ALPHA-GLUCOSIDASES; ANIMALS; BIGNONIACEAE; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INTESTINES; MALE; MICE; MICE, INBRED BALB C; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STARCH; TOLBUTAMIDE; TRIGLYCERIDES;

ANIMALIA; BIGNONIACEAE; RATTUS; TECOMA STANS;

EID: 67449123051     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.04.033     Document Type: Article

References (37)

1. Aguilar L.C., Macías S., Chagoya A., Cárdenas A., Díaz P., and Cantú J.M. Antidiabetic activity of Tecoma stans in rats. Fitoterapia 64 (1993) 304-305
2. Aguilar-Salinas C.A., Velazquez M.O., Gómez-Pérez F.J., Gonzalez C.A., Esqueda A.L., Molina C.V., Rull-Rodrigo J.A., Tapia C.R., and Encuesta Nacional de Salud 2000 Group. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care 26 (2003) 2021-2026
3. Andrade-Cetto A., and Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. Journal of Ethnopharmacology 78 (2001) 145-149
4. Arai I., Amagaya S., Komatsu Y., Okada M., Hayashi T., Kasai M., Arisawa M., and Momose Y. Improving effects of the extracts from Eugenia uniflora on hyperglycemia and hypertriglyceridemia in mice. Journal of Ethnopharmacology 68 (1999) 307-314
5. Argáez-López N., Wacher N.H., Kumate-Rodríguez J., Cruz M., Talavera J., Rivera-Arce E., Lozoya X., and DIMSS Study Group. The use of complementary and alternative medicine therapies in type 2 diabetic patients in Mexico. Diabetes Care 26 (2003) 2470-2471
6. Asano N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13 (2003) 93R-104R
7. Beta T., Nam S., Dexter J.E., and Sapirstein H.D. Phenolic content and antioxidant activity of pearled wheat and roller-milled fractions. Cereal Chemistry 82 (2005) 390-393
8. Costantino L., Lins A.P., Barlocco D., Celotti F., el-Abady S.A., Brunetti T., Maggi R., and Antolini L. Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans. Pharmazie 58 (2003) 140-142
9. Costantino L., Raimondi L., Pirisino R., Brunetti T., Pessotto P., Giannessi F., Lins A.P., Barlocco D., Antolini L., and El-Abady S.A. Isolation and pharmacological activities of the Tecoma stans alkaloids. Il Farmaco 58 (2003) 781-785
10. Fujita H., Yamagami T., and Ohshima K. Long-term ingestion of a fermented soybean-derived Touchi-extract with α-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. Journal of Nutrition 131 (2001) 2105-2108
11. Hammouda Y., and Khalafallah N. Stability of tecomine, the major antidiabetic factor of Tecoma stans (Juss.) f. bignoniaceae. Journal of Pharmaceutical Sciences 60 (1971) 1142-1145
12. Hammouda Y., Rashid A.K., and Amer M.S. Hypoglycaemic properties of tecomine and tecostanine. Journal of Pharmacy and Pharmacology 16 (1964) 833-834
13. Hernández-Galicia H., Aguilar-Contreras A., Aguilar-Santamaría L., Román-Ramos R., Chavez-Miranda A.A., García-Vega L.M., Flores-Saenz J.L., and Alarcón-Aguilar F.J. Studies on hypoglycemic activity of Mexican medicinal plants. Proceedings of the Western Pharmacology Society 45 (2002) 118-124
14. Herrera-Arellano A., Aguilar-Santamaría L., García-Hernández B., Nicasio-Torres P., and Tortoriello J. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine 11 (2004) 561-566
15. Hwang J.K., Kong T.W., Baek N.I., and Pyun Y.R. α-Glycosidase inhibitory activity of hexagalloylglucose from the galls of Quercus infectoria. Planta Medica 66 (2002) 273-274
16. Johnston K.L., Clifford M.N., and Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. American Journal of Clinical Nutrition 78 (2003) 728-733
17. Lozoya X., Aguilar A., and Camacho J.R. Encuesta sobre el uso actual de las plantas en la Medicina Tradicional Mexicana. Revista Médica del Instituto Mexicano del Seguro Social 25 (1987) 283-291
18. Lozoya-Meckes M., and Mellado-Campos V. Is the Tecoma stans infusion an antidiabetic remedy?. Journal of Ethnopharmacology 14 (1985) 1-9
19. a ed. (1969), Andrés Botas, México pp. 330-333
20. Matsuura H., Asakawa C., Kurimoto M., and Mizutani J. α glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa. Bioscience, Biotechnology and Biochemistry 66 (2002) 1576-1578
21. Meckes-Lozoya M., and Ibáñez-Camacho R. Hepatic glycogenolysis produced by intraperitoneal administration of total extract of Tecoma stans in rats. Archivos de Investigación Médica 16 (1985) 387-393
22. Naranjo J.P., Corral-Salvadó A., Rivero-Jiménez G., Fernández-Menéndez M., and Pérez-Santoya P.E. Efecto hipoglicemiante del extracto fluido de Tecoma stans Linn en roedores. Revista Cubana de Medicina Militar 8 (2003) 13-17
23. Nicasio P., Aguilar-Santamaría L., Aranda E., Ortiz S., and González M. Hypoglycemic effect and chlorogenic acid content in two Cecropia species. Phytotherapy Research 19 (2005) 661-664
24. Nyarko A.K., Sittie A.A., and Addy M.E. The basis for the antihyperglycaemic activity of Indigofera arrecta in the rat. Phytotherapy Research 7 (1993) 1-4
25. Olaiz-Fernández G., Rivera-Dommarco J., Sharmah-Levy T., Rojas R., Villalpando-Hernández S., Hernández-Avila M., and Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutrición 2006 (2006), Instituto Nacional de Salud Pública, México pp. 75-82
26. Ortiz-Andrade R.R., García-Jiménez S., Castillo-España P., Ramírez-Avila G., Villalobos-Molina R., and Estrada-Soto S. Alpha-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: an anti-hyperglycemic agent. Journal of Ethnopharmacology 109 (2007) 48-53
27. Pérez G.R.M., Ocegueda Z.A., Muñoz L.J.L., Avila A.J.G., and Morrow W.W. A study of the hypoglucemic effect of some Mexican plants. Journal of Ethnopharmacology 12 (1984) 253-262
28. Rodrguez de Sotillo D.V., and Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. The Journal of Nutritional Biochemistry 13 (2002) 717-726
29. Román-Ramos R., Flores-Saenz J.L., Partida-Hernández G., Lara-Lemus A., and Alarcón-Aguilar F. Experimental study of the hypoglycemic effect of some antidiabetic plants. Archivos de Investigación Médica 22 (1991) 87-93
30. Sachdewa A., and Khemani L.D. Effect of Hibiscus rosa sinensis Linn. ethanol flower extract on blood glucose and lipid profile in streptozotocin induced diabetes in rats. Journal of Ethnopharmacology 89 (2003) 61-66
31. Shapiro K., and Gong W.C. Natural products used for diabetes. Journal of the American Pharmaceutical Association 42 (2002) 217-226
32. Sugumaran M., Mohan V., Kishore G., Sharma H., and Vaidyanathan C. Phenolic acids of Tecoma stans. Indian Journal of Experimental Biology 13 (1975) 93
33. Urizar N.L., Liverman A.B., Dodds D.T., Silva F.V., Ordentlich P., Yan Y., Gonzalez F.J., Heyman R.A., Mangelsdorf D.J., and Moore D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296 (2002) 1703-1706
34. Winkelman M. Frequently used medicinal plants in Baja California Norte. Journal of Ethnopharmacology 18 (1986) 109-131
35. World Health Organization, Diabetes Programme. 2006. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/index.html (Accessed July 25, 2008).
36. Ye F., Shen Z., and Xie M. Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori) in normal and diabetic rats and mice. Phytomedicine 9 (2002) 161-166
37. Yoshikawa M., Nishida N., Shimoda H., Takada M., Kawahara Y., and Matsuda H. Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan 121 (2001) 371-378